Rheumatic Syndromes Associated with Immune-Checkpoint Inhibitors: A Single-Center Cohort of 61 Patients

被引：0

作者：

Richter, Michael ^{[1
]}

Crowson, Cynthia S. ^{[2
]}

Kottschade, Lisa ^{[3
]}

Finnes, Heidi ^{[3
]}

Markovic, Svetomir N. ^{[4
]}

Thanarajasingam, Uma ^{[5
]}

机构：

[1] Mayo Clin, Internal Med, Rochester, MN USA

[2] Mayo Clin, Coll Med & Sci, Hlth Sci Res, Rochester, MN USA

[3] Mayo Clin, Oncol, Rochester, MN USA

[4] Mayo Clin, Dept Med & Oncol, Rochester, MN USA

[5] Mayo Clin, Dept Rheumatol, Rochester, MN USA

来源：

ARTHRITIS & RHEUMATOLOGY | 2018年 / 70卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

1914

引用

页数：2

共 50 条

[21] Hematologic toxicities induced by Immune checkpoint inhibitors: a single-center, retrospective study
Yuda, Sayako
Yuma, Tada
Yasuhiro, Shingai
Shigeo, Fuji
Hiroaki, Masaie
Jun, Ishikawa
ANNALS OF ONCOLOGY, 2022, 33 : S505 - S505
[22] Clinical characteristics of rheumatic syndromes associated with checkpoint inhibitors therapy
Kostine, Marie
Truchetet, Marie-Elise
Schaeverbeke, Thierry
RHEUMATOLOGY, 2019, 58 : 68 - 74
[23] Clinical features of vulvar and vaginal malignant melanomas and the effects of immune checkpoint inhibitors in Japanese patients: a single-center, retrospective cohort study
Horisaki, Ken
Yoshikawa, Shusuke
Omata, Wataru
Tsutsumida, Arata
Kiyohara, Yoshio
MELANOMA RESEARCH, 2025, 35 (01) : 67 - 74
[24] Impact of Immune Checkpoint Inhibitors on AKI Incidence and Mortality in Patients with Bladder Cancer: A Single-Center Experience
Lee, Shina
Kim, Seung-Jung
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 35 (10):
[25] Immune checkpoint inhibitors in patients with pretreated Hodgkin's lymphoma: a Korean single-center, retrospective study
Hur, Joon Young
Yoon, Sang Eun
Kim, Seok Jin
Kim, Won Seog
BLOOD RESEARCH, 2020, 55 (02) : 85 - 90
[26] Endocrine-related adverse events associated with immune-checkpoint inhibitors in patients with melanoma
Kassi, Eva
Angelousi, Anna
Asonitis, Nikolaos
Diamantopoulos, Panagiotis
Anastasopoulou, Amalia
Papaxoinis, George
Kokkinos, Michalis
Giovanopoulos, Ilias
Kyriakakis, Georgios
Petychaki, Fotini
Savelli, Akrivi
Benopoulou, Olga
Gogas, Helen
CANCER MEDICINE, 2019, 8 (15): : 6585 - 6594
[27] BIOMARKER TRENDS AND OUTCOMES IN PATIENTS RECEIVING IMMUNE-CHECKPOINT INHIBITORS
Vasbinder, Alexi
Chen, YeeAnn
Gradone, Allison
Azam, Tariq
Perry, Daniel
Shadid, Husam
Anderson, Elizabeth
Catalan, Tonimarie
Blakely, Pennelope K.
Nelapudi, Namratha
Fardous, Mohamad
Adie, Sarah
Pogue, Kristen
Leja, Monika Jacqueline
Yentz, Sarah
Schneider, Bryan
Hayek, Salim
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (08) : 2366 - 2366
[28] TRANSCRIPTOMIC CHANGES IN CANCER PATIENTS TREATED WITH IMMUNE-CHECKPOINT INHIBITORS
Shek, Dmitrii
Gao, Bo
Lai, Joey
Yoon, Won-Hee
Moujaber, Tania
Nagrial, Adnan
Carlino, Matteo
Read, Scott
Ahlenstiel, Golo
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A552 - A552
[29] Autoantibody positivity predicts severity of rheumatic immune-related adverse events to immune-checkpoint inhibitors
Campochiaro, Corrado
Farina, Nicola
Tomelleri, Alessandro
Ferrara, Roberto
Viola, Silvia
Lazzari, Chiara
De Luca, Giacomo
Raggi, Daniele
Bulotta, Alessandra
Matucci-Cerinic, Marco
Necchi, Andrea
Garassino, Marina
Gregorc, Vanesa
Dagna, Lorenzo
EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2022, 103 : 95 - 99
[30] Clinical factors associated with outcome in solid tumor patients treated with immune-checkpoint inhibitors: a single institution retrospective analysis
Qian Qin
Tomi Jun
Bo Wang
Vaibhav G. Patel
George Mellgard
Xiaobo Zhong
Mahalya Gogerly-Moragoda
Anish B. Parikh
Amanda Leiter
Emily J. Gallagher
Parissa Alerasool
Philip Garcia
Himanshu Joshi
Matthew MBBS
William K. Galsky
Che-Kai Oh
Discover Oncology, 13

← 1 2 3 4 5 →